Employees Retirement System of Texas’s 10x Genomics TXG Stock Holding History

Employees Retirement System of Texas’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-16,273	Closed	-$317K	–	367
2024 Q2	$317K	Hold	16,273	–	–	﹤0.01%	288
2024 Q1	$611K	Buy	16,273 +8,000	+97%	+$351K	0.01%	290
2023 Q4	$463K	Buy	+8,273	New	+$360K	0.01%	304
2022 Q2	–	Sell	-24,000	Closed	-$1.83M	–	775
2022 Q1	$1.83M	Buy	24,000 +11,000	+85%	+$962K	0.02%	574
2021 Q4	$1.94M	Hold	13,000	–	–	0.02%	561
2021 Q3	$1.89M	Hold	13,000	–	–	0.02%	577
2021 Q2	$2.55M	Hold	13,000	–	–	0.03%	504
2021 Q1	$2.35M	Hold	13,000	–	–	0.03%	538
2020 Q4	$1.84M	Buy	+13,000	New	+$1.89M	0.03%	498

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Employees Retirement System of Texas's TXG Position: Q3 2024 in Review

Employees Retirement System of Texas sold out of 10x Genomics (TXG) in Q3 2024, closing a stake of 16,273 shares — an estimated $317K sold.

Employees Retirement System of Texas first reported a position in TXG in Q4 2020 and held it in 9 quarters. The position peaked at $2.55M in Q2 2021. 266 funds tracked by Wall St. Rank hold TXG as of Q3 2024.

Employees Retirement System of Texas reported no remaining 10x Genomics position as of Q3 2024 after selling out during the quarter.
Employees Retirement System of Texas sold 16,273 10x Genomics shares in Q3 2024, an estimated $317K.
Employees Retirement System of Texas first reported a position in 10x Genomics in Q4 2020 and held it in 9 quarters.
Employees Retirement System of Texas's 10x Genomics position peaked at $2.55M in Q2 2021.
266 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2024.

Based on Employees Retirement System of Texas's 13F filing for Q3 2024, filed 14 Nov 2024.